Share Email Print
cover

Proceedings Paper

Fluorescently labeled bevacizumab in human breast cancer: defining the classification threshold
Author(s): Maximilian Koch; Johannes S. de Jong; Jürgen Glatz; Panagiotis Symvoulidis; Laetitia E. Lamberts; Arthur L. L. Adams; Mariëtte E. G. Kranendonk; Anton G. T. Terwisscha van Scheltinga; Michaela Aichler; Liesbeth Jansen; Jakob de Vries; Marjolijn N. Lub-de Hooge; Carolien P. Schröder; Annelies Jorritsma-Smit; Matthijs D. Linssen; Esther de Boer; Bert van der Vegt; Wouter B. Nagengast; Sjoerd G. Elias; Sabrina Oliveira; Arjen J. Witkamp; Willem P. Th. M. Mali; Elsken Van der Wall; P. Beatriz Garcia-Allende; Paul J. van Diest; Elisabeth G. E. de Vries; Axel Walch; Gooitzen M. van Dam; Vasilis Ntziachristos
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

In-vivo fluorescently labelled drug (bevacizumab) breast cancer specimen where obtained from patients. We propose a new structured method to determine the optimal classification threshold in targeted fluorescence intra-operative imaging.

Paper Details

Date Published: 28 July 2017
PDF: 4 pages
Proc. SPIE 10411, Clinical and Preclinical Optical Diagnostics, 104110F (28 July 2017); doi: 10.1117/12.2286062
Show Author Affiliations
Maximilian Koch, Technische Univ. München (Germany)
Helmholtz Zentrum München GmbH (Germany)
Johannes S. de Jong, Utrecht Univ. (Netherlands)
Jürgen Glatz, Technische Univ. München (Germany)
Helmholtz Zentrum München GmbH (Germany)
Panagiotis Symvoulidis, Technische Univ. München (Germany)
Helmholtz Zentrum München GmbH (Germany)
Laetitia E. Lamberts, Univ. of Groningen (Netherlands)
Arthur L. L. Adams, Utrecht Univ. (Netherlands)
Mariëtte E. G. Kranendonk, Utrecht Univ. (Netherlands)
Anton G. T. Terwisscha van Scheltinga, Univ. of Groningen (Netherlands)
Michaela Aichler, Helmholtz Zentrum München GmbH (Germany)
Liesbeth Jansen, Univ. of Groningen (Netherlands)
Jakob de Vries, Univ. of Groningen (Netherlands)
Marjolijn N. Lub-de Hooge, Univ. of Groningen (Netherlands)
Carolien P. Schröder, Univ. of Groningen (Netherlands)
Annelies Jorritsma-Smit, Univ. of Groningen (Netherlands)
Matthijs D. Linssen, Univ. of Groningen (Netherlands)
Esther de Boer, Univ. of Groningen (Netherlands)
Bert van der Vegt, Univ. of Groningen (Netherlands)
Wouter B. Nagengast, Univ. of Groningen (Netherlands)
Sjoerd G. Elias, Utrecht Univ. (Netherlands)
Sabrina Oliveira, Utrecht Univ. (Netherlands)
Arjen J. Witkamp, Utrecht Univ. (Netherlands)
Willem P. Th. M. Mali, Utrecht Univ. (Netherlands)
Elsken Van der Wall, Utrecht Univ. (Netherlands)
P. Beatriz Garcia-Allende, Technische Univ. München (Germany)
Helmholtz Zentrum München GmbH (Germany)
Paul J. van Diest, Utrecht Univ. (Netherlands)
Elisabeth G. E. de Vries, Univ. of Groningen (Netherlands)
Axel Walch, Helmholtz Zentrum München GmbH (Germany)
Gooitzen M. van Dam, Univ. of Groningen (Netherlands)
Vasilis Ntziachristos, Technische Univ. München (Germany)
Helmholtz Zentrum München GmbH (Germany)


Published in SPIE Proceedings Vol. 10411:
Clinical and Preclinical Optical Diagnostics
J. Quincy Brown; Ton G. van Leeuwen, Editor(s)

© SPIE. Terms of Use
Back to Top